Reply - 27/12/12

| Disclosure of potential conflict of interest: J. P. Abonia has received research support from the National Institutes of Health, Ception Therapeutics, and the Children’s Digestive Health and Nutrition Foundation. P. E. Putnam is on the speakers’ bureau for Abbott Nutrition and Nutricia. M. E. Rothenberg has an equity interest in Teva Pharmaceuticals, is Chief Scientific Officer of Immune Pharmaceuticals, is a Journal of Allergy and Clinical Immunology Associate Editor, is on the American Partnership for the Eosinophilic Disorders Medical Advisory Board, is on the steering committee for the International Eosinophil Society and the International Group of Eosinophilic Researchers, and is the inventor of several patents owned by Cincinnati Children's Hospital. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 131 - N° 1
P. 243-244 - janvier 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
